Find News

Filter articles

Showing 71 to 80 of 2294 results

Win for ResMed in patent war with Fisher & Paykel


The Munich District Court in Germany has found that sleep masks produced by Fisher & Paykel Healthcare infringe a European patent owned by ResMed.

Teva asks FTC to reopen Actavis and Watson merger decision


The US Federal Trade Commission yesterday said that Teva Pharmaceuticals has asked the commission to reopen and modify its decision and order regarding the 2012 merger of Actavis and Watson Pharmaceuticals.

United Therapeutics signs 3D bioprinting technology deal

Israel, US23-10-2018

Maryland-based United Therapeutics has inked a licence, development and commercialisation agreement with CollPlant, an Israeli biotech company, for 3D bioprinted lung transplants.

Federal Circuit refuses tribal immunity rehearing


In a blow to Allergan and the Saint Regis Mohawk Tribe, the US Court of Appeals for the Federal Circuit yesterday refused to reconsider an earlier decision that rejected use of tribal sovereign immunity in inter partes reviews.

Novartis to acquire radiopharma treatment developer

Switzerland, US22-10-2018

Novartis is planning to acquire Endocyte, an Indiana-based biotech, to accelerate its development of radiopharmaceuticals.

AbbVie enters Humira licensing deal with Fresenius Kabi

EU, US22-10-2018

AbbVie has announced that it has entered into a licensing deal with Germany-based pharmaceutical company Fresenius Kabi.

Amgen injects £50m in UK gene-sequencing company

UK, US19-10-2018

Amgen has invested £50 million ($66 million) in Oxford Nanopore Technologies, a UK company specialising in DNA/RNA sequencing technology.

EFPIA warns that SPC waiver will weaken EU IP framework


The supplementary protection certificate manufacturing waiver “sends a worrying global signal that the EU is weakening its IP framework”, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA).

US agencies to bolster cybersecurity of medical devices


The US Food and Drug Administration has announced that it has partnered with the US Department of Homeland Security as part of the FDA’s aim to strengthen cybersecurity in healthcare.

FDA lifts hold on first human CRISPR trial


The US Food and Drug Administration has allowed the first US-based human trial of CRISPR, the gene-editing technology, to proceed.

Showing 71 to 80 of 2294 results